US$ 28.77
fda halts glp-1 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Safety Check - National
Description
Diabetes Care 47 (2), 280284 (2024)

What we really need is to lower the unit cost for the drugs. He also said that while the Ozempic and other GLP-1 drugs fight diabetes, the American Medical Association named obesity a disease as well in 2013

Nat Immunol

The interaction of glucagon with GLP-1R is important for insulin secretion in the -cells [365]

Data availability The data supporting the findings of this study are available within the paper and its Supplementary Information

What is GLP-1 and why does it matter
